bpc-157 dosage duration peptide sciences clinical trials BPC-157 Dosing (Common Protocols), πΉ Oral / Subcutaneous, β’ 500 mcg daily, β’ Duration: 6 weeks, πΉ Intramuscular / Peritendinous, β’ 1 mg daily, β’ Duration: 6 weeks, β οΈ Note:, Not approved by FDA or BPC-157 for Gut, Tendon &
Description
That alone felt like a miraclebut the kindness and empathy shown to me made it even more meaningful
PMC 11045288
Use an old dosing chart from a previous prescription
as a result, most controlled efficacy studies referenced to date use parenteral dosing with defined schedules to sustain ERR activation
And always remember to dispose of the syringe and the needle in a safe and secure manner after every use
